Corinna Schoelch - Publications

Dual Glucagon and GLP-1 Receptor Agonist Survodutide Improves Biomarkers of Beta-Cell Function and Insulin Sensitivity in People With Type 2 Diabetes or Living With Overweight/Obesity.

Journal: Diabetes, obesity & metabolism

Published: January 21, 2026

Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.

Journal: Hepatology (Baltimore, Md.)

Published: December 17, 2025

Weight reduction-dependent/-independent effects of survodutide on liver endpoints: Mediation analysis of a phase 2 trial in MASH.

Journal: Hepatology (Baltimore, Md.)

Published: December 17, 2025

Hepatic improvement within 27 days of avenciguat treatment in Child-Pugh A cirrhosis detected by an oral cholate challenge test.

Journal: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Published: March 19, 2024

Obesity-related inflammatory protein signature in cardiovascular clinical outcomes: results from the Gutenberg Health Study.

Journal: Obesity (Silver Spring, Md.)

Published: December 04, 2023

Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib study.

Journal: Hepatology communications

Published: March 03, 2023

A randomised Phase IIa trial of amine oxidase copper-containing 3 (AOC3) inhibitor BI 1467335 in adults with non-alcoholic steatohepatitis.

Journal: Nature communications

Published: November 21, 2022

Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906.

Journal: Diabetes, obesity & metabolism

Published: October 06, 2022

NAFLD and NASH biomarker qualification in the LITMUS consortium - Lessons learned.

Journal: Journal of hepatology

Published: September 30, 2022

An exploratory study investigating biomarkers associated with autoimmune pulmonary alveolar proteinosis (aPAP).

Journal: Scientific reports

Published: October 12, 2021

The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.

Journal: Journal of magnetic resonance imaging : JMRI

Published: September 23, 2021

Safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses of BI 187004, an inhibitor of 11beta-hydroxysteroid dehydrogenase-1, in healthy male volunteers with overweight or obesity.

Journal: Clinical diabetes and endocrinology

Published: October 30, 2020